Clorox (NYSE:CLX) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Clorox (NYSE:CLX) had its price objective boosted by equities research analysts at JPMorgan Chase & Co. from $167.00 to $171.00 in a report released on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 7.93% from the stock’s current price.

Several other equities research analysts also recently weighed in on the stock. Evercore ISI decreased their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. DA Davidson boosted their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. Finally, Barclays boosted their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Clorox currently has an average rating of “Hold” and an average price target of $157.23.

Clorox Price Performance

Shares of NYSE CLX opened at $158.43 on Thursday. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37. The firm has a fifty day simple moving average of $164.48 and a 200 day simple moving average of $156.16. The company has a market capitalization of $19.61 billion, a PE ratio of 55.20, a P/E/G ratio of 2.90 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the firm earned $0.49 earnings per share. Clorox’s quarterly revenue was up 27.0% on a year-over-year basis. On average, sell-side analysts forecast that Clorox will post 6.87 EPS for the current year.

Institutional Trading of Clorox

A number of institutional investors have recently modified their holdings of CLX. Insight Folios Inc increased its holdings in Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after acquiring an additional 63 shares during the period. HCR Wealth Advisors increased its holdings in Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after acquiring an additional 68 shares during the period. SPC Financial Inc. increased its holdings in Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after acquiring an additional 75 shares during the period. Massmutual Trust Co. FSB ADV increased its holdings in Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after acquiring an additional 75 shares during the period. Finally, Empower Advisory Group LLC increased its holdings in Clorox by 4.5% during the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after acquiring an additional 78 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.